FORM
THIS DOCUMENT IS A TECHNICAL ILLUSTRATION OF HOW CERTAIN DISCLOSURES IN SEC FILINGS ARE TO BE TAGGED. IT DOES NOT INDICATE WHICH PARTICULAR DISCLOSURES MUST BE INCLUDED AND/OR TAGGED IN COMMISSION FILINGS, AND IT DOES NOT CONSTITUTE LEGAL GUIDANCE OF ANY SORT.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
| ☐ Smaller Reporting Company | ☐ Emerging Growth Company |
The de-SPAC transaction timeframe is
The following table illustrates the difference between the public offering price per unit and our NTBV per share, as adjusted to give effect to this offering and assuming redemption of our public shares at varying levels and the full exercise and no exercise of the over-allotment option:
| As of September 10, 2024 |
||||||||||||||||||||||||||||||||
| Offering Price of $ |
25% of Maximum Redemption |
50% of Maximum Redemption |
75% of Maximum Redemption |
Maximum Redemption |
||||||||||||||||||||||||||||
| NTBV |
NTBV | Difference between NTBV and Offering Price |
NTBV | Difference between NTBV and Offering Price |
NTBV | Difference between NTBV and Offering Price |
NTBV | Difference between NTBV and Offering Price |
||||||||||||||||||||||||
| Assuming Full Exercise of Over-Allotment Option |
| |||||||||||||||||||||||||||||||
| $ |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||
| Assuming No Exercise of Over-Allotment Option |
| |||||||||||||||||||||||||||||||
| $ |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||
For each of the redemption scenarios above, the NTBV was calculated as follows:
| No Redemptions | 25% of Maximum Redemptions |
50% of Maximum Redemptions |
75% of Maximum Redemptions |
Maximum Redemptions |
||||||||||||||||||||||||||||||||||||
| Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
|||||||||||||||||||||||||||||||
| Public offering price |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Net tangible book deficit before this offering |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Increase attributable to public shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Pro forma net tangible book value after this offering and the sale of the placement shares |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Dilution to public shareholders |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Percentage of dilution to public shareholders |
29.60 | % | 29.50 | % | 36.30 | % | 36.20 | % | 46.90 | % | 46.70 | % | 65.80 | % | 65.60 | % | 110.00 | % | 109.80 | % | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| No Redemptions | 25% of Maximum Redemptions |
50% of Maximum Redemptions |
75% of Maximum Redemptions |
Maximum Redemptions |
||||||||||||||||||||||||||||||||||||
| Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
Without Over- Allotment |
With Over- Allotment |
|||||||||||||||||||||||||||||||
| Numerator: |
||||||||||||||||||||||||||||||||||||||||
| Net tangible book deficit before this offering |
$ | ( |
$ | ( |
( |
( |
( |
( |
( |
( |
( |
( |
||||||||||||||||||||||||||||
| Net proceeds from this offering and the sale of the placement shares(1) |
||||||||||||||||||||||||||||||||||||||||
| Plus: Offering costs accrued for or paid in advance, excluded from tangible book value |
||||||||||||||||||||||||||||||||||||||||
| Less: Deferred underwriting commissions |
( |
( |
( |
( |
( |
( |
( |
( |
( |
( |
||||||||||||||||||||||||||||||
| Less: Overallotment liability |
( |
| ( |
| ( |
| ( |
| ( |
| ||||||||||||||||||||||||||||||
| Less: Amounts paid for redemptions(2) |
| | ( |
( |
( |
( |
( |
( |
( |
( |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| $ | $ | |
$ | $ | $ | $ | $ | $ | $ | ( |
( |
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Denominator: |
||||||||||||||||||||||||||||||||||||||||
| Ordinary shares outstanding prior to this offering |
||||||||||||||||||||||||||||||||||||||||
| Ordinary shares forfeited if over-allotment is not exercised |
( |
| ( |
| ( |
| ( |
| ( |
| ||||||||||||||||||||||||||||||
| Ordinary shares offered and sale of placement shares |
||||||||||||||||||||||||||||||||||||||||
| Less: Ordinary shares redeemed |
| | ( |
( |
( |
( |
( |
( |
( |
( |
||||||||||||||||||||||||||||||
| Placement shares |
||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| (1) | Expenses applied against gross proceeds include offering expenses of approximately $600,000 and underwriting commissions of $0.20 per unit (including any units sold pursuant to the underwriters option to purchase additional units), or $4,000,000 in the aggregate, payable to the underwriters in this offering (excluding deferred underwriting commissions). See Use of Proceeds. |
| (2) | Upon the consummation of our initial business combination, the deferred underwriting commissions would be paid as follows: $0.40 per unit $8,000,000 in the aggregate or up to an additional $1,200,000 in the aggregate if the underwriters over-allotment option is exercised in full payable to the underwriters in the Proposed Offering. See also Underwriting for a description of compensation and other items of value payable to the underwriter. |
| (3) | If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial shareholders, directors, officers, advisors or their affiliates may purchase shares or public warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See Proposed Business Effecting Our Initial Business Combination Permitted Purchases and other transactions with respect to our securities. |